Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults

Sean R. Williamson, Antonio Lopez-Beltran, Gregory T. MacLennan, Rodolfo Montironi, Liang Cheng

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In children and young adults, urothelial carcinoma and other epithelial neoplasms of the urinary bladder are rare. When these tumors do occur, they appear to exhibit unique clinicopathologic features, with preferentially low-grade morphology and decreased likelihood of recurrence and progression, although some debate exists regarding their biologic behavior. In contrast, a subset of soft tissue tumors is more commonly seen in pediatric patients, with rhabdomyosarcoma being the most common malignancy in this location. Likewise, inflammatory myofibroblastic tumor may be a source of differential diagnostic complexity. In the setting of previous bladder augmentation, patients appear to have a distinctive disposition to develop epithelial neoplasms later in life. Data regarding the molecular characteristics and clinical behavior of pediatric bladder tumors are, with the exception of rhabdomyosarcoma, less well understood than those of adult/elderly patients. In this article, we review the distinguishing features of urinary bladder neoplasms in pediatric and young adult patients, with special emphasis on unique clinicopathologic features, molecular-genetic abnormalities, and syndromic associations of urothelial neoplasms in this patient population.

Original languageEnglish
Pages (from-to)414-426
Number of pages13
JournalUrologic Oncology: Seminars and Original Investigations
Volume31
Issue number4
DOIs
StatePublished - May 2013

Fingerprint

Urinary Bladder Neoplasms
Young Adult
Urinary Bladder
Glandular and Epithelial Neoplasms
Rhabdomyosarcoma
Neoplasms
Pediatrics
Molecular Biology
Carcinoma
Recurrence
Population

Keywords

  • Augmentation cystoplasty
  • Fibroblast growth factor receptor 3
  • Fluorescence in situ hybridization
  • Neoplasia
  • P53 Mutation
  • Urinary bladder
  • Urothelial carcinoma

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults. / Williamson, Sean R.; Lopez-Beltran, Antonio; MacLennan, Gregory T.; Montironi, Rodolfo; Cheng, Liang.

In: Urologic Oncology: Seminars and Original Investigations, Vol. 31, No. 4, 05.2013, p. 414-426.

Research output: Contribution to journalArticle

Williamson, Sean R. ; Lopez-Beltran, Antonio ; MacLennan, Gregory T. ; Montironi, Rodolfo ; Cheng, Liang. / Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults. In: Urologic Oncology: Seminars and Original Investigations. 2013 ; Vol. 31, No. 4. pp. 414-426.
@article{4ae630dab94441fdadda185985f3d146,
title = "Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults",
abstract = "In children and young adults, urothelial carcinoma and other epithelial neoplasms of the urinary bladder are rare. When these tumors do occur, they appear to exhibit unique clinicopathologic features, with preferentially low-grade morphology and decreased likelihood of recurrence and progression, although some debate exists regarding their biologic behavior. In contrast, a subset of soft tissue tumors is more commonly seen in pediatric patients, with rhabdomyosarcoma being the most common malignancy in this location. Likewise, inflammatory myofibroblastic tumor may be a source of differential diagnostic complexity. In the setting of previous bladder augmentation, patients appear to have a distinctive disposition to develop epithelial neoplasms later in life. Data regarding the molecular characteristics and clinical behavior of pediatric bladder tumors are, with the exception of rhabdomyosarcoma, less well understood than those of adult/elderly patients. In this article, we review the distinguishing features of urinary bladder neoplasms in pediatric and young adult patients, with special emphasis on unique clinicopathologic features, molecular-genetic abnormalities, and syndromic associations of urothelial neoplasms in this patient population.",
keywords = "Augmentation cystoplasty, Fibroblast growth factor receptor 3, Fluorescence in situ hybridization, Neoplasia, P53 Mutation, Urinary bladder, Urothelial carcinoma",
author = "Williamson, {Sean R.} and Antonio Lopez-Beltran and MacLennan, {Gregory T.} and Rodolfo Montironi and Liang Cheng",
year = "2013",
month = "5",
doi = "10.1016/j.urolonc.2010.08.003",
language = "English",
volume = "31",
pages = "414--426",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults

AU - Williamson, Sean R.

AU - Lopez-Beltran, Antonio

AU - MacLennan, Gregory T.

AU - Montironi, Rodolfo

AU - Cheng, Liang

PY - 2013/5

Y1 - 2013/5

N2 - In children and young adults, urothelial carcinoma and other epithelial neoplasms of the urinary bladder are rare. When these tumors do occur, they appear to exhibit unique clinicopathologic features, with preferentially low-grade morphology and decreased likelihood of recurrence and progression, although some debate exists regarding their biologic behavior. In contrast, a subset of soft tissue tumors is more commonly seen in pediatric patients, with rhabdomyosarcoma being the most common malignancy in this location. Likewise, inflammatory myofibroblastic tumor may be a source of differential diagnostic complexity. In the setting of previous bladder augmentation, patients appear to have a distinctive disposition to develop epithelial neoplasms later in life. Data regarding the molecular characteristics and clinical behavior of pediatric bladder tumors are, with the exception of rhabdomyosarcoma, less well understood than those of adult/elderly patients. In this article, we review the distinguishing features of urinary bladder neoplasms in pediatric and young adult patients, with special emphasis on unique clinicopathologic features, molecular-genetic abnormalities, and syndromic associations of urothelial neoplasms in this patient population.

AB - In children and young adults, urothelial carcinoma and other epithelial neoplasms of the urinary bladder are rare. When these tumors do occur, they appear to exhibit unique clinicopathologic features, with preferentially low-grade morphology and decreased likelihood of recurrence and progression, although some debate exists regarding their biologic behavior. In contrast, a subset of soft tissue tumors is more commonly seen in pediatric patients, with rhabdomyosarcoma being the most common malignancy in this location. Likewise, inflammatory myofibroblastic tumor may be a source of differential diagnostic complexity. In the setting of previous bladder augmentation, patients appear to have a distinctive disposition to develop epithelial neoplasms later in life. Data regarding the molecular characteristics and clinical behavior of pediatric bladder tumors are, with the exception of rhabdomyosarcoma, less well understood than those of adult/elderly patients. In this article, we review the distinguishing features of urinary bladder neoplasms in pediatric and young adult patients, with special emphasis on unique clinicopathologic features, molecular-genetic abnormalities, and syndromic associations of urothelial neoplasms in this patient population.

KW - Augmentation cystoplasty

KW - Fibroblast growth factor receptor 3

KW - Fluorescence in situ hybridization

KW - Neoplasia

KW - P53 Mutation

KW - Urinary bladder

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84876714470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876714470&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2010.08.003

DO - 10.1016/j.urolonc.2010.08.003

M3 - Article

C2 - 20884253

AN - SCOPUS:84876714470

VL - 31

SP - 414

EP - 426

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 4

ER -